Technology company Körber has introduced a new manufacturing execution system tailored specifically for smaller pharmaceutical sites, where the complexity and cost of a full-scale MES implementation have historically made it difficult to move away from paper-based processes. The new solution, called PAS-X Neo, is designed with small and medium-sized manufacturers in mind, as well as smaller facilities operating within larger pharmaceutical organisations.
One of the standout aspects of PAS-X Neo is its emphasis on fast and straightforward pharma MES deployment. Körber states that standardised process templates are built into the system to support an implementation timeline of approximately two months — a considerably shorter window compared to traditional MES rollouts. The software is delivered as fully managed software as a service (SaaS), which means it requires no local infrastructure on the customer’s side to operate. Additionally, Körber says that pre-validated components are included to meaningfully reduce the volume of validation work typically required during system setup.
Compliance and Data Integrity at the Core
PAS-X Neo incorporates audit trails and electronic signatures as core features, with built-in controls designed to support data integrity and regulatory compliance with both US and European requirements for electronic records. These capabilities are particularly relevant for small pharma manufacturers who must meet stringent compliance standards but may lack the resources of larger enterprises to manage complex validation and documentation processes.
The system was officially launched on 11 November 2026 at the Biotech and Medical Device World Summit held in San Diego, following its initial public announcement in May of the same year.
Scalability and Existing Hardware Ecosystem
Körber has built flexibility into PAS-X Neo by allowing manufacturers to add further capabilities as their operations grow. If required, there is also a pathway to scale up to Körber’s full PAS-X MES platform. This approach to pharma MES deployment enables smaller sites to start with what they need today while retaining the option to expand over time.
Building on Established Hardware Partnerships
Körber has previously worked to simplify the deployment of its existing PAS-X MES through hardware collaborations. In September 2025, the company announced a partnership with Pepperl+Fuchs covering VisuNet human-machine interfaces, which are designed to allow operators to use the software in cleanrooms and hazardous production environments. As part of that collaboration, the two companies developed joint installation recommendations aimed at reducing manual configuration work during setup.
The introduction of PAS-X Neo reflects Körber’s continued effort to make pharmaceutical MES technology more accessible to small pharma manufacturers and facilities that have previously faced barriers to digital adoption.
















